The medicine has anti-inflammatory properties and has antispasmodic effect on smooth muscles of the bronchi.
Intended for the treatment of acute and chronic inflammation of upper respiratory tract and respiratory tract infections (otitis media, sinusitis, rhinitis, nasopharyngitis, tracheitis, rinotracheobronchitis, bronchitis), chronic obstructive pulmonary disease. It is used in the complex treatment of bronchial asthma, as well as in the treatment of seasonal and perennial allergic rhinitis and other allergic manifestations of the respiratory system and otolaryngology. It is indicated for respiratory symptoms of measles, influenza and for the symptomatic treatment of pertussis.
Trade name: Amispiron ІС
INN: fenspiride
Chemical name: 8-(2-phenylethyl)-1-oxa-3,8-diaza-spiro [4.5] decan-2-one
Pharmaceutical form: tablets 0.08 g
Pharmacotherapeutic group: An agent which influences the respiratory system. Other medications for regular use in obstructive diseases of the respiratory system.
ATC code R03D X03.
Registration number: UA / 13800/01/01
Registration Date / Expires: 19/08/14 / 08.19.19
Packing: tablets 0.08 g №10 and №20.
Shelf life: 2 years
Legal category: prescription only medicine
Search